CLINICAL_TRIALS
trial_result
· 2015-12-31
Clinical Trial Update: Gilenya in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
This document reports the completion and results posting of a Phase 2 trial of fingolimod (Gilenya) in amyotrophic lateral sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2015-12-31